A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation

Journal of Immunology

Volumn 175, Issue 2, 2005, Pages 1257-1266

  Ali, Simi ^a   Robertson, Helen ^a   Wain, Julie H ^a   Isaacs, John D ^a   Malik, Ghada ^a   Kirby, John A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR AGONIST; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2B; CHEMOKINE RECEPTOR CCR3; GLYCOSAMINOGLYCAN; MONOCYTE CHEMOTACTIC PROTEIN 3; MUTANT PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

AIR POUCH; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL MIGRATION; ENDOTHELIUM; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MIGRATION; MOUSE; MUTATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN VARIANT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RESPIRATORY SYSTEM; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 23244432481     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.2.1257     Document Type: Article

References (47)

1. Van Coillie, E., J. Van Damme, and G. Opdenakker. 1999. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 10: 61-86.
2. Menten, P., P. Proost, S. Struyf, E. Van Coillie, W. Put, J. P. Lenaerts, R. Conings, J. M. Jaspar, D. De Groote, A. Billiau, et al. 1999. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-α/β and interferon-γ reveals MCP-3 heterogeneity. Eur. J. Immunol. 29: 678-685.
3. Menten, P., A. Wuyts, and J. Van Damme. 2001. Monocyte chemotactic protein-3. Eur. Cytokine Netw. 12: 554-560.
4. Kim, K. S., K. Rajarathnam, I. Clark-Lewis, and B. D. Sykes. 1996. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett. 395: 277-282.
5. Meunier, S., J. M. Bernassau, J. C. Guillemot, P. Ferrara, and H. Darbon. 1997. Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy. [Published erratum appears in 1997 Biochemistry 36: 10600.] Biochemistry 36: 4412-4422.
6. Romagnani, S. 2002. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38: 881-885.
7. Fioretti, F., D. Fradelizi, A. Stoppacciaro, S. Ramponi, L. Ruco, A. Minty, S. Sozzani, C. Garlanda, A. Vecchi, and A. Mantovani. 1998. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J. Immunol. 161: 342-346.
8. Turnbull, J., A. Powell, and S. Guimond. 2001. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11: 75-82.
9. Lortat-Jacob, H., A. Grosdidier, and A. Imberty. 2002. Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA 99: 1229-1234.
10. Wagner, L., O. O. Yang, E. A. Garcia-Zepeda, Y. Ge, S. A. Kalams, B. D. Walker, M. S. Pasternack, and A. D. Luster. 1998. β-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391: 908-911.
11. Rot, A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13: 291-294.
12. Hardy, L. A., T. A. Booth, E. K. Lau, T. M. Handel, S. Ali, and J. A. Kirby. 2004. Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration. Lab. Invest. 84: 81-90.
13. Hileman, R. E., J. R. Fromm, J. M. Weiler, and R. J. Linhardt. 1998. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays 20: 156-167.
14. Sadir, R., F. Baleux, A. Grosdidier, A. Imberty, and H. Lortat-Jacob. 2001. Characterization of the stromal cell-derived factor-1α-heparin complex. J. Biol. Chem. 276: 8288-8296.
15. Koopmann, W., and M. S. Krangel. 1997. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1α. J. Biol. Chem. 272: 10103-10109.
16. Koopmann, W., C. Ediriwickrema, and M. S. Krangel. 1999. Structure and function of the glycosaminoglycan binding site of chemokine macrophage- inflammatory protein-1β. J. Immunol. 163: 2120-2127.
17. Martin, L., C. Blanpain, P. Garnier, V. Wittamer, M. Parmentier, and C. Vita. 2001. Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 40: 6303-6318.
18. Proudfoot, A. E., S. Fritchley, F. Borlat, J. P. Shaw, F. Vilbois, C. Zwahlen, A. Trkola, D. Marchant, P. R. Clapham, and T. N. Wells. 2001. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276: 10620-10626.
19. Kuschert, G. S. V., A. J. Hoogewerf, A. E. I. Proudfoot, C.-W. Chung, R. M. Cooke, R. E. Hubbard, T. N. C. Wells, and P. N. Sanderson. 1998. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37: 11193-11201.
20. Chakravarty, L., L. Rogers, T. Quach, S. Breckenridge, and P. E. Kolattukudy. 1998. Lysine 58 and histidine 66 at the C-terminal α-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273: 29641-29647.
21. Peterson, F. C., E. S. Elgin, T. J. Nelson, F. Zhang, T. J. Hoeger, R. J. Linhardt, and B. F. Volkman. 2004. Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J. Biol. Chem. 279: 12598-12604.
22. Ali, S., A. C. Palmer, B. Banerjee, S. J. Fritchley, and J. A. Kirby. 2000. Examination of the function of RANTES, MIP-1α, and MIP-1β following interaction with heparin-like glycosaminoglycans. J. Biol. Chem. 275: 11721-11727.
23. Graham, G. J., P. C. Wilkinson, R. J. Nibbs, S. Lowe, S. O. Kolset, A. Parker, M. G. Freshney, M. L. Tsang, and I. B. Pragnell. 1996. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1α by mutagenesis of the proteoglycan binding site. EMBO J. 15: 6506-6515.
24. Ali, S., A. C. Palmer, S. J. Fritchley, Y. Maley, and J. A. Kirby. 2001. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Biochem. J. 358: 737-745.
25. Ali, S., S. J. Fritchley, B. T. Chaffey, and J. A. Kirby. 2002. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology 12: 535-543.
26. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100: 1885-1890.
27. Wain, J. H., J. M. Palmer, J. A. Kirby, and S. Ali. 2003. Rapid site-directed mutagenesis of chemokines and their purification from a bacterial expression system. J. Immunol. Methods 279: 233-249.
28. Wain, J. H., J. A. Kirby, and S. Ali. 2002. Leucocyte chemotaxis: examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by monocyte chemoattractant proteins-1, -2, -3, and -4. Clin. Exp. Immunol. 127: 436-444.
29. Nibbs, R. J. B., T. W. Salcedo, J. D. M. Campbell, X. T. Yao, Y. L. Li, B. Nardelli, H. S. Olsen, T. S. Morris, A. E. I. Proudfoot, V. P. Patel, and G. J. Graham. 2000. C-C chemokine receptor 3 antagonism by the β-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap. J. Immunol. 164: 1488-1497.
30. Ades, E. W., F. J. Candal, R. A. Swerlick, V. G. George, S. Summers, D. C. Bosse, and T. J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99: 683-690.
31. Luscinskas, F. W., H. Ding, P. Tan, D. Cumming, T. F. Tedder, and M. E. Gerritsen. 1996. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-α-activated vascular endothelium under flow in vitro. J. Immunol. 157: 326-335.
32. Edwards, J. C., A. D. Sedgwick, and D. A. Willoughby. 1981. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134: 147-156.
33. McNearney, T., B. A. Baethge, S. Cao, R. Alam, J. R. Lisse, and K. N. Westlund. 2004. Excitatory amino acids, TNF-α, and chemokine levels in synovial fluids of patients with active arthropathies. Clin. Exp. Immunol. 137: 621-627.
34. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568.
35. Rot, A., and U. H. Von Andrian. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22: 891-928.
36. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91: 385-395.
37. Carter, N. M., S. Ali, and J. A. Kirby. 2003. Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate. J. Cell Sci. 116: 3591-3600.
38. Ali, S., L. A. Hardy, and J. A. Kirby. 2003. Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans? Transplantation 75: 1773-1782.
39. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38: 12959-12968.
40. Patel, D. D., W. Koopmann, T. Imai, L. P. Whichard, O. Yoshie, and M. S. Krangel. 2001. Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99: 43-52.
41. Chung, I. Y., Y. H. Kim, M. K. Choi, Y. J. Noh, C. S. Park, Y. Kwon do, D. Y. Lee, Y. S. Lee, H. S. Chang, and K. S. Kim. 2004. Eotaxin and monocyte chemotactic protein-3 use different modes of action. Biochem. Biophys. Res. Commun. 314: 646-653.
42. al-Mughales, J., T. H. Blyth, J. A. Hunter, and P. C. Wilkinson. 1996. The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines. Clin. Exp. Immunol. 106: 230-236.
43. Barlic, J., M. H. Khandaker, E. Mahon, J. Andrews, M. E. DeVries, G. B. Mitchell, R. Rahimpour, C. M. Tan, S. S. Ferguson, and D. J. Kelvin. 1999. β-arrestins regulate interleukin-8-induced CXCR1 internalization. J. Biol. Chem. 274: 16287-16294.
44. 2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J. Biol. Chem. 278: 12729-12736.
45. Hecht, I., L. Cahalon, R. Hershkoviz, A. Lahat, S. Franitza, and O. Lider. 2003. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Int. Immunol. 15: 29-38.
46. Aragay, A. M., M. Mellado, J. M. Frade, A. M. Martin, M. C. Jimenez-Sainz, A. C. Martinez, and F. Mayor, Jr. 1998. Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc. Natl. Acad. Sci. USA 95: 2985-2990.
47. Pollok-Kopp, B., K. Schwarze, V. K. Baradari, and M. Oppermann. 2003. Analysis of ligand-stimulated CC chemokine receptor 5 (CCR5) phosphorylation in intact cells using phosphosite-specific antibodies. J. Biol. Chem. 278: 2190-2198.